These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 27751772)

  • 1. Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study.
    Arcilla MS; van Hattem JM; Haverkate MR; Bootsma MCJ; van Genderen PJJ; Goorhuis A; Grobusch MP; Lashof AMO; Molhoek N; Schultsz C; Stobberingh EE; Verbrugh HA; de Jong MD; Melles DC; Penders J
    Lancet Infect Dis; 2017 Jan; 17(1):78-85. PubMed ID: 27751772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Travel to Asia and traveller's diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum β-lactamase-producing Enterobacteriaceae-a prospective cohort study.
    Reuland EA; Sonder GJ; Stolte I; Al Naiemi N; Koek A; Linde GB; van de Laar TJ; Vandenbroucke-Grauls CM; van Dam AP
    Clin Microbiol Infect; 2016 Aug; 22(8):731.e1-7. PubMed ID: 27223840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Carriage Of Multiresistant Bacteria After Travel (COMBAT) prospective cohort study: methodology and design.
    Arcilla MS; van Hattem JM; Bootsma MC; van Genderen PJ; Goorhuis A; Schultsz C; Stobberingh EE; Verbrugh HA; de Jong MD; Melles DC; Penders J
    BMC Public Health; 2014 Apr; 14():410. PubMed ID: 24775515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of travel-associated faecal colonisation with ESBL-producing Enterobacteriaceae - A one year follow-up study.
    ÖstholmBalkhed Å; Tärnberg M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A;
    PLoS One; 2018; 13(10):e0205504. PubMed ID: 30356258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended-spectrum β-lactamase-producing Enterobacteriaceae colonisation in long-term overseas business travellers.
    Mizuno Y; Miura Y; Yamaguchi T; Matsumoto T
    Travel Med Infect Dis; 2016; 14(6):561-567. PubMed ID: 27769900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae: incidence and risk factors.
    Ostholm-Balkhed A; Tärnberg M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A;
    J Antimicrob Chemother; 2013 Sep; 68(9):2144-53. PubMed ID: 23674762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany.
    Lübbert C; Straube L; Stein C; Makarewicz O; Schubert S; Mössner J; Pletz MW; Rodloff AC
    Int J Med Microbiol; 2015 Jan; 305(1):148-56. PubMed ID: 25547265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High carriage rate of ESBL-producing Enterobacteriaceae at presentation and follow-up among travellers with gastrointestinal complaints returning from India and Southeast Asia.
    Barreto Miranda I; Ignatius R; Pfüller R; Friedrich-Jänicke B; Steiner F; Paland M; Dieckmann S; Schaufler K; Wieler LH; Guenther S; Mockenhaupt FP
    J Travel Med; 2016 Feb; 23(2):tav024. PubMed ID: 26858272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High acquisition rate of extended-spectrum β-lactamase-producing Enterobacteriaceae among French military personnel on mission abroad, without evidence of inter-individual transmission.
    Maataoui N; Mayet A; Duron S; Delacour H; Mentré F; Laouenan C; Desvillechabrol D; Cokelaer T; Meynard JB; Ducher A; Andremont A; Armand-Lefèvre L; Mérens A
    Clin Microbiol Infect; 2019 May; 25(5):631.e1-631.e9. PubMed ID: 30099136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High colonization rates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in Swiss travellers to South Asia- a prospective observational multicentre cohort study looking at epidemiology, microbiology and risk factors.
    Kuenzli E; Jaeger VK; Frei R; Neumayr A; DeCrom S; Haller S; Blum J; Widmer AF; Furrer H; Battegay M; Endimiani A; Hatz C
    BMC Infect Dis; 2014 Oct; 14():528. PubMed ID: 25270732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquisition of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) carriage after exposure to systemic antimicrobials during travel: Systematic review and meta-analysis.
    Wuerz TC; Kassim SS; Atkins KE
    Travel Med Infect Dis; 2020; 37():101823. PubMed ID: 32755674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae is common 12 months after infection and is related to strain factors.
    Titelman E; Hasan CM; Iversen A; Nauclér P; Kais M; Kalin M; Giske CG
    Clin Microbiol Infect; 2014 Aug; 20(8):O508-15. PubMed ID: 24450760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae.
    Kantele A; Lääveri T; Mero S; Vilkman K; Pakkanen SH; Ollgren J; Antikainen J; Kirveskari J
    Clin Infect Dis; 2015 Mar; 60(6):837-46. PubMed ID: 25613287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) among travellers to Africa: destination-specific data pooled from three European prospective studies.
    Lääveri T; Vlot JA; van Dam AP; Häkkinen HK; Sonder GJB; Visser LG; Kantele A
    BMC Infect Dis; 2018 Jul; 18(1):341. PubMed ID: 30037325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International travel is a risk factor for extended-spectrum β-lactamase-producing Enterobacteriaceae acquisition in children: A case-case-control study in an urban U.S. hospital.
    Strysko JP; Mony V; Cleveland J; Siddiqui H; Homel P; Gagliardo C
    Travel Med Infect Dis; 2016; 14(6):568-571. PubMed ID: 27890813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for colonization with extended-spectrum beta-lactamase producing Enterobacteriaceae in healthcare students on clinical assignment abroad: A prospective study.
    Angelin M; Forsell J; Granlund M; Evengård B; Palmgren H; Johansson A
    Travel Med Infect Dis; 2015; 13(3):223-9. PubMed ID: 25982453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in a population of Dutch travellers: A cross-sectional study.
    Arcilla MS; Van Hattem JM; Bootsma MCJ; van Genderen PJJ; Goorhuis A; Grobusch MP; Klaassen CHW; Oude Lashof AM; Schultsz C; Stobberingh EE; de Jong MD; Penders J; Verbrugh HA; Melles DC
    Travel Med Infect Dis; 2020; 33():101547. PubMed ID: 31862246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of gut microbiota in travel-related acquisition of extended spectrum β-lactamase-producing Enterobacteriaceae.
    Peng Y; Liang S; Poonsuk K; On H; Li SW; Maurin MMP; Chan CH; Chan CL; Sin ZY; Tun HM
    J Travel Med; 2021 Apr; 28(3):. PubMed ID: 33615366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal colonization with extended-spectrum beta-lactamase producing Enterobacterales (ESBL-PE) during long distance travel: A cohort study in a German travel clinic (2016-2017).
    Meurs L; Lempp FS; Lippmann N; Trawinski H; Rodloff AC; Eckardt M; Klingeberg A; Eckmanns T; Walter J; Lübbert C;
    Travel Med Infect Dis; 2020; 33():101521. PubMed ID: 31770602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relating knowledge, attitude and practice of antibiotic use to extended-spectrum beta-lactamase-producing Enterobacteriaceae carriage: results of a cross-sectional community survey.
    Mo Y; Seah I; Lye PSP; Kee XLJ; Wong KYM; Ko KKK; Ong RT; Tambyah PA; Cook AR
    BMJ Open; 2019 Mar; 9(3):e023859. PubMed ID: 30842108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.